John M. Climaco - 12 Apr 2023 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Chief Executive Officer, Director
Signature
/s/ John M. Climaco
Issuer symbol
CNSP
Transactions as of
12 Apr 2023
Net transactions value
+$10,408
Form type
4
Filing time
14 Apr 2023, 16:20:05 UTC
Previous filing
31 Mar 2023
Next filing
01 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNSP Common Stock Purchase $10,408 +15,000 +50% $0.6939 45,010 12 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $0.677 to $0.70. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.